Actual Roles and Desirable Roles of Pharmacists for Their Practice in Patients with Peritoneal Dialysis
Article Sidebar
Main Article Content
Abstract
Objective: To explain the actual roles and specify the desirable roles of pharmacists for their practice in peritoneal dialysis (PD) patients. Methods: This study was a qualitative research. Data were collected by using semi-structured interview with 29 key informants. Twenty six key informants were from Maharaj Nakhon Ratchasima Hospital and Udon Thani Hospital, consisting of 8 nephrologists, 6 PD nurses and 12 pharmacists. Three expert pharmacists were also interviewed. Content analysis was conducted by using ATLAS.ti version 8.4.18. Results: Actual roles of pharmacists for their practice in PD patients consisted of 6 roles including practice management, research, drug procurement and inventory management, patient care, medication delivery, and monitoring and evaluating the effectiveness of pharmaceutical care. The desirable roles consisted of 7 roles including 6 actual roles and one additional role, i.e., medication preparation. Conclusion: Pharmacy practice in PD patients does not limit to patient care role but extends to other roles. All roles involve team working of many pharmacists. All work of pharmacists in taking responsibility in drug therapy leads to conclusion that the role of pharmacists in this area is the role of managing drug system in PD patients. This result could be applied to the improvement of pharmacy service for PD patients.
Article Details
ผลการวิจัยและความคิดเห็นที่ปรากฏในบทความถือเป็นความคิดเห็นและอยู่ในความรับผิดชอบของผู้นิพนธ์ มิใช่ความเห็นหรือความรับผิดชอบของกองบรรณาธิการ หรือคณะเภสัชศาสตร์ มหาวิทยาลัยสงขลานครินทร์ ทั้งนี้ไม่รวมความผิดพลาดอันเกิดจากการพิมพ์ บทความที่ได้รับการเผยแพร่โดยวารสารเภสัชกรรมไทยถือเป็นสิทธิ์ของวารสารฯ
References
Ingsathit A, Thakkinstian A, Chaiprasert A, Sangtha wan P, Gojaseni P, Kiattisunthorn K, et al. Preva lence and risk factors of chronic kidney disease in Thai adult population: Thai SEEK study. Nephrol Dial Transplant 2010; 25: 1567-75.
Murray CJL, Lopez AD, Naghavi M, Wang H. Global, regional, and national life expectancy, all-cause mortality, and cause-specific mortality for 249 causes of death, 1980–2015: a systematic analysis for the Global Burden of Disease Study 2015. Lancet 2016; 388: 1459–544.
Hill NR, Fatoba ST, Oke JL, Hirst JA, O’Callaghan CA, Lasserson DS, et al. Global prevalence of chronic kidney disease–A systematic review and meta-analysis. PLoS ONE 2016; 7: 1-18.
National Health Security Office. National health security fund handbook year 2017 [online]. 2017 [cited Jul 12, 2020]. Available from: www.nhso. go.th.
Vadcharavivad S. Pharmacotherapy in chronic kidney disease. Bangkok: Text and Journal Publication; 2017.
Wankul S. Effect of pharmacist participation in patient care team for continuous ambulatory peritoneal dialysis (CAPD) patients. Thai Journal of Hospital Pharmacy 2012; 22: 115-22.
Chuemongkon W, Sukyoo P, Kruetiwa N. The effects of medication counseling on drug compliance in peritoneal dialysis patients at peritoneal dialysis clinic in Nopparat Rajathanee Hospital, Bangkok. Isan Journal of Pharmaceutical Sciences 2014; 10: 339-53.
Wetphakin K, Ngamkham J. The impact of pharmaceutical care to the quantity and cost of unused medication in end-stage renal disease patients undergo hemodialysis and peritoneal dialysis. Thai Journal of Hospital Pharmacy 2017; 27: 67-77.
Wattanaphan C, Pitak P, Methachaiwiwat T. Assess ments of pharmaceutical care in continuous ambula tory peritoneal dialysis clinic in nan hospital. Clinical Pharmacy Journal 2017; 23: 21-8.
Lindberg M, Lindberg P, Wikstrom B. Medication discrepancy: A concordance problem between dialysis patients and caregivers. Scand J Urol Nephrol 2007; 41: 546-52.
Njeri LW, Ogallo WO, Nyamu DG, Opanga SA, Birichi AR. Medication related problems among adult chronic kidney disease patients in a sub‑Saharan tertiary hospital. Int J Clin Pharm 2018; 40: 1217-24.
Griva K, Lai AY, Lim HA, Yu Z, Foo MWY, Newman SP. Non-adherence in patients on peritoneal dialysis: A systematic review. PLoS ONE 2014; 9: 1-11.
Geldine CG, Bhengu B, Manwere A. Adherence of adult chronic kidney disease patients with regard to their dialysis, medication, dietary and fluid restriction. Res J Health Sci 2017; 5: 3-17.
Hepler CD, Strand LM. Opportunities and responsi bilities in pharmaceutical care. Am J Hosp Pharm 1990; 47: 533-43.
Strand LM, Cipolle RJ, Morley PC. Pharmaceutical care: An introduction. Michigan: Upjohn Company; 1992.
Cipolle RJ, Strand LM, Morley PC. Pharmaceutical care practice: The clinician’s guide. 2 nd ed. New York: McGraw-Hill Companies; 2004.
Salgado TM, Moles R, Benrimoj SI, Fernandez-Llimos F. Exploring the role of renal pharmacists in outpatient dialysis centers: a qualitative study. Int J Clin Pharm 2012; 34: 569–78.
Jennifer AB, Rose MB, Cyndy AC, Sandra FD, Kelly TE, Laurel MM, et al. ASHP guidelines: Minimum standard for ambulatory care pharmacy practice. Am J Health-Syst Pharm 2015; 72: 1221-36.
Stemer G, Lemmens-Gruber R. Clinical pharmacy activities in chronic kidney disease and end-stage renal disease patients: a systematic literature review. BMC Nephrology 2011; 35: 1-12.
Mateti UV, Nagappa AN, Attur RP, Nagarapu SP, Rangaswamy D. Impact of pharmaceutical care on the health-related quality of life among hemodia lysis patients – A multicenter randomized controlled study. Saudi J Kidney Dis Transpl 2017; 28: 1293-306.
Al-Abdelmuhsin L, Al-Ammari M, , Babelghaith SD, Wajid S, Asiri YA , Almetawazi MS, et al. Pharmacist-led medication counseling for patients undergoing hemodialysis: A path to better adherence. Int J Environ Res Public Health 2020; 17: 1-9.
Management Science for Health. MDS-3: Managing Access to medicines and health technologies [online]. 2012 [cited May 7, 2020]. Available from: www.msh.org/resources/mds-3-managing-access-to-medicines-and-health-technologies.
